C260-2189 Screening compound: N-[(2-chlorophenyl)methyl]-3-(1-{[(4-methylphenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)propanamide

C260-2189 Screening compound: N-[(2-chlorophenyl)methyl]-3-(1-{[(4-methylphenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)propanamide
C260-2189 Screening compound: N-[(2-chlorophenyl)methyl]-3-(1-{[(4-methylphenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C260-2189
N-[(2-chlorophenyl)methyl]-3-(1-{[(4-methylphenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C260-2189

Molecular Formula

C27H25ClN4O4 (C27 H25 ClN4 O4)

Compound Name

N-[(2-chlorophenyl)methyl]-3-(1-{[(4-methylphenyl)carbamoyl]methyl}-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)propanamide

IUPAC name

N-[(2-chlorophenyl)methyl]-3-(1-{[(4-methylphenyl)carbamoyl]methyl}-24-dioxo-1234-tetrahydroquinazolin-3-yl)propanamide

SMILES

Cc(cc1)ccc1NC(CN(c(cccc1)c1C(N1CCC(NCc(cccc2)c2Cl)=O)=O)C1=O)=O

InChI

InChI=1S/C27H25ClN4O4/c1-18-10-12-20(13-11-18)30-25(34)17-32-23-9-5-3-7-21(23)26(35)31(27(32)36)15-14-24(33)29-16-19-6-2-4-8-22(19)28/h2-13H,14-17H2,1H3,(H,29,33)(H,30,34)

InChI Key

UDXHSMUJKWVVGB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14738444

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

504.97

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.123

Distribution Coefficient, logD

4.123

Water Solubility, LogSw

-4.34

Polar Surface Area

78.866

Acid Dissociation Constant (pKa)

12.67

Base Dissociation Constant (pKb)

3.47

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

18.50

C260-2189 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Antiviral Annotated Library (21441 compounds)

Human Kinases Annotated Library (2415 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer

References: we are preparing a list of scientific research reports with C260-2189 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C260-2189?
Check Price and Availability of C260-2189, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C260-2189 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C260-2189
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C260-2189
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C260-2189 available by request